These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32982437)

  • 1. The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer.
    Łukaszewicz-Zając M; Pączek S; Mroczko P; Kulczyńska-Przybik A
    Cancer Manag Res; 2020; 12():8435-8443. PubMed ID: 32982437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer.
    Łukaszewicz-Zając M; Zajkowska M; Pączek S; Kulczyńska-Przybik A; Safiejko K; Juchimiuk M; Kozłowski L; Mroczko B
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
    Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
    Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer.
    Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L
    Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL8-CXCR1/2 pathways in cancer.
    Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
    Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines-What Is Their Role in Colorectal Cancer?
    Pączek S; Łukaszewicz-Zając M; Mroczko B
    Cancer Control; 2020; 27(1):1073274820903384. PubMed ID: 32103675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
    Gu L; Yao Y; Chen Z
    Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of
    Rasool M; Natesan Pushparaj P; Karim S
    Saudi J Biol Sci; 2021 Nov; 28(11):6045-6049. PubMed ID: 34764737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.
    Pawluczuk E; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma.
    Chen X; Jin R; Chen R; Huang Z
    Int J Clin Exp Pathol; 2018; 11(2):1036-1045. PubMed ID: 31938199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chemokines and chemokine receptors in human colon cancer.
    Erreni M; Bianchi P; Laghi L; Mirolo M; Fabbri M; Locati M; Mantovani A; Allavena P
    Methods Enzymol; 2009; 460():105-21. PubMed ID: 19446722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF.
    Di Cesare S; Marshall JC; Logan P; Antecka E; Faingold D; Maloney SC; Burnier MN
    J Carcinog; 2007 Jan; 6():2. PubMed ID: 17261188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
    Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
    Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.
    le Rolle AF; Chiu TK; Fara M; Shia J; Zeng Z; Weiser MR; Paty PB; Chiu VK
    J Transl Med; 2015 Jun; 13():199. PubMed ID: 26104296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.